May 30, 2024
5:1
For every share held, investors received 5. The price per share adjusted from $683.55 to $136.71.
The split itself did not change the total investment value.
Balaxi Pharmaceuticals Limited (NSE:BALAXI) operates in the Medical distributors industry.
Balaxi Pharmaceuticals Limited company overviewBalaxi Pharmaceuticals Limited's most recent stock split was on May 30, 2024. It was a 5-for-1 forward split, so shareholders received 5 shares for every share they held.
Balaxi Pharmaceuticals Limited has split its stock once. This history records one forward split, on May 30, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Balaxi Pharmaceuticals Limited's 5-for-1 split on May 30, 2024, every share became 5 shares.
Balaxi Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on May 30, 2024, 2 years ago. Companies announce splits in advance, and any new NSE:BALAXI split will appear on this page.
Already premium?